Literature DB >> 34906470

The importance of automation in genetic diagnosis: Lessons from analyzing an inherited retinal degeneration cohort with the Mendelian Analysis Toolkit (MATK).

Erin Zampaglione1, Matthew Maher1, Emily M Place1, Naomi E Wagner2, Stephanie DiTroia3, Katherine R Chao3, Eleina England3, Broad Cmg3, Andrew Catomeris4, Sherwin Nassiri5, Seraphim Himes6, Joey Pagliarulo7, Charles Ferguson1, Eglé Galdikaité-Braziené1, Brian Cole1, Eric A Pierce1, Kinga M Bujakowska8.   

Abstract

PURPOSE: In Mendelian disease diagnosis, variant analysis is a repetitive, error-prone, and time consuming process. To address this, we have developed the Mendelian Analysis Toolkit (MATK), a configurable, automated variant ranking program.
METHODS: MATK aggregates variant information from multiple annotation sources and uses expert-designed rules with parameterized weights to produce a ranked list of potentially causal solutions. MATK performance was measured by a comparison between MATK-aided and human-domain expert analyses of 1060 families with inherited retinal degeneration (IRD), analyzed using an IRD-specific gene panel (589 individuals) and exome sequencing (471 families).
RESULTS: When comparing MATK-assisted analysis with expert curation in both the IRD-specific gene panel and exome sequencing (1060 subjects), 97.3% of potential solutions found by experts were also identified by the MATK-assisted analysis (541 solutions identified with MATK of 556 solutions found by conventional analysis). Furthermore, MATK-assisted analysis identified 114 additional potential solutions from the 504 cases unsolved by conventional analysis.
CONCLUSION: MATK expedites the process of identification of likely solving variants in Mendelian traits, and reduces variability stemming from human error and researcher bias. MATK facilitates data reanalysis to keep up with the constantly improving annotation sources and next-generation sequencing processing pipelines. The software is open source and available at https://gitlab.com/matthew_maher/mendelanalysis.
Copyright © 2021 American College of Medical Genetics and Genomics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Automation; Mendelian analysis; Variant ranking

Mesh:

Year:  2021        PMID: 34906470      PMCID: PMC9200473          DOI: 10.1016/j.gim.2021.09.015

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.864


  38 in total

Review 1.  The molecular basis of human retinal and vitreoretinal diseases.

Authors:  Wolfgang Berger; Barbara Kloeckener-Gruissem; John Neidhardt
Journal:  Prog Retin Eye Res       Date:  2010-03-31       Impact factor: 21.198

2.  Predicting Splicing from Primary Sequence with Deep Learning.

Authors:  Kishore Jaganathan; Sofia Kyriazopoulou Panagiotopoulou; Jeremy F McRae; Siavash Fazel Darbandi; David Knowles; Yang I Li; Jack A Kosmicki; Juan Arbelaez; Wenwu Cui; Grace B Schwartz; Eric D Chow; Efstathios Kanterakis; Hong Gao; Amirali Kia; Serafim Batzoglou; Stephan J Sanders; Kyle Kai-How Farh
Journal:  Cell       Date:  2019-01-17       Impact factor: 41.582

3.  Efficient In Silico Identification of a Common Insertion in the MAK Gene which Causes Retinitis Pigmentosa.

Authors:  Kinga M Bujakowska; Joseph White; Emily Place; Mark Consugar; Jason Comander
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

4.  Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencing.

Authors:  Mark B Consugar; Daniel Navarro-Gomez; Emily M Place; Kinga M Bujakowska; Maria E Sousa; Zoë D Fonseca-Kelly; Daniel G Taub; Maria Janessian; Dan Yi Wang; Elizabeth D Au; Katherine B Sims; David A Sweetser; Anne B Fulton; Qin Liu; Janey L Wiggs; Xiaowu Gai; Eric A Pierce
Journal:  Genet Med       Date:  2014-11-20       Impact factor: 8.822

5.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

6.  Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).

Authors:  Erin Rooney Riggs; Erica F Andersen; Athena M Cherry; Sibel Kantarci; Hutton Kearney; Ankita Patel; Gordana Raca; Deborah I Ritter; Sarah T South; Erik C Thorland; Daniel Pineda-Alvarez; Swaroop Aradhya; Christa Lese Martin
Journal:  Genet Med       Date:  2019-11-06       Impact factor: 8.822

7.  Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources.

Authors:  Sebastian Köhler; Leigh Carmody; Nicole Vasilevsky; Julius O B Jacobsen; Daniel Danis; Jean-Philippe Gourdine; Michael Gargano; Nomi L Harris; Nicolas Matentzoglu; Julie A McMurry; David Osumi-Sutherland; Valentina Cipriani; James P Balhoff; Tom Conlin; Hannah Blau; Gareth Baynam; Richard Palmer; Dylan Gratian; Hugh Dawkins; Michael Segal; Anna C Jansen; Ahmed Muaz; Willie H Chang; Jenna Bergerson; Stanley J F Laulederkind; Zafer Yüksel; Sergi Beltran; Alexandra F Freeman; Panagiotis I Sergouniotis; Daniel Durkin; Andrea L Storm; Marc Hanauer; Michael Brudno; Susan M Bello; Murat Sincan; Kayli Rageth; Matthew T Wheeler; Renske Oegema; Halima Lourghi; Maria G Della Rocca; Rachel Thompson; Francisco Castellanos; James Priest; Charlotte Cunningham-Rundles; Ayushi Hegde; Ruth C Lovering; Catherine Hajek; Annie Olry; Luigi Notarangelo; Morgan Similuk; Xingmin A Zhang; David Gómez-Andrés; Hanns Lochmüller; Hélène Dollfus; Sergio Rosenzweig; Shruti Marwaha; Ana Rath; Kathleen Sullivan; Cynthia Smith; Joshua D Milner; Dorothée Leroux; Cornelius F Boerkoel; Amy Klion; Melody C Carter; Tudor Groza; Damian Smedley; Melissa A Haendel; Chris Mungall; Peter N Robinson
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

8.  Toward automation of germline variant curation in clinical cancer genetics.

Authors:  Vignesh Ravichandran; Zarina Shameer; Yelena Kemel; Michael Walsh; Karen Cadoo; Steven Lipkin; Diana Mandelker; Liying Zhang; Zsofia Stadler; Mark Robson; Kenneth Offit; Joseph Vijai
Journal:  Genet Med       Date:  2019-02-21       Impact factor: 8.822

9.  Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers.

Authors:  Aaron M Wenger; Harendra Guturu; Jonathan A Bernstein; Gill Bejerano
Journal:  Genet Med       Date:  2016-07-21       Impact factor: 8.822

10.  The Ensembl Variant Effect Predictor.

Authors:  William McLaren; Laurent Gil; Sarah E Hunt; Harpreet Singh Riat; Graham R S Ritchie; Anja Thormann; Paul Flicek; Fiona Cunningham
Journal:  Genome Biol       Date:  2016-06-06       Impact factor: 13.583

View more
  2 in total

1.  StrVCTVRE: A supervised learning method to predict the pathogenicity of human genome structural variants.

Authors:  Andrew G Sharo; Zhiqiang Hu; Shamil R Sunyaev; Steven E Brenner
Journal:  Am J Hum Genet       Date:  2022-01-14       Impact factor: 11.025

2.  Prevalence of pathogenic germline variants in the circulating tumor DNA testing.

Authors:  Yoshihiro Yamamoto; Keita Fukuyama; Masashi Kanai; Tomohiro Kondo; Masahiro Yoshioka; Tadayuki Kou; Pham Nguyen Quy; Reiko Kimura-Tsuchiya; Takahiro Yamada; Shigemi Matsumoto; Shinji Kosugi; Manabu Muto
Journal:  Int J Clin Oncol       Date:  2022-07-23       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.